237 related articles for article (PubMed ID: 11467346)
1. AMP-activated protein kinase: possible target for treatment of type 2 diabetes.
Winder WW
Diabetes Technol Ther; 2000; 2(3):441-8. PubMed ID: 11467346
[TBL] [Abstract][Full Text] [Related]
2. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle.
Lemieux K; Konrad D; Klip A; Marette A
FASEB J; 2003 Sep; 17(12):1658-65. PubMed ID: 12958172
[TBL] [Abstract][Full Text] [Related]
3. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
4. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
5. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
[TBL] [Abstract][Full Text] [Related]
6. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
7. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.
Ai H; Ihlemann J; Hellsten Y; Lauritzen HP; Hardie DG; Galbo H; Ploug T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1291-300. PubMed ID: 12006359
[TBL] [Abstract][Full Text] [Related]
8. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Musi N; Goodyear LJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
[TBL] [Abstract][Full Text] [Related]
9. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
Kurth-Kraczek EJ; Hirshman MF; Goodyear LJ; Winder WW
Diabetes; 1999 Aug; 48(8):1667-71. PubMed ID: 10426389
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle.
Stoppani J; Hildebrandt AL; Sakamoto K; Cameron-Smith D; Goodyear LJ; Neufer PD
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1239-48. PubMed ID: 12388122
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle.
Miyamoto L; Toyoda T; Hayashi T; Yonemitsu S; Nakano M; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Ogawa Y; Inoue G; Fushiki T; Nakao K
J Appl Physiol (1985); 2007 Mar; 102(3):1007-13. PubMed ID: 17122373
[TBL] [Abstract][Full Text] [Related]
12. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase and muscle glucose uptake.
Musi N; Goodyear LJ
Acta Physiol Scand; 2003 Aug; 178(4):337-45. PubMed ID: 12864738
[TBL] [Abstract][Full Text] [Related]
14. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
16. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase.
Holmes BF; Sparling DP; Olson AL; Winder WW; Dohm GL
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1071-6. PubMed ID: 16105857
[TBL] [Abstract][Full Text] [Related]
17. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
18. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
Russell RR; Bergeron R; Shulman GI; Young LH
Am J Physiol; 1999 Aug; 277(2):H643-9. PubMed ID: 10444490
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle.
Ryder JW; Long YC; Nilsson E; Mahlapuu M; Zierath JR
J Physiol; 2005 Sep; 567(Pt 2):379-86. PubMed ID: 15975979
[TBL] [Abstract][Full Text] [Related]
20. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
